TP53 and malignant colon neoplasm: We observed a clear reduction in p53 expression in Hep G2 treated with miR-125b-EVs while no differences were evidenced in the colon cancer cell line HCT 116 undergoing the same treatment, confirming the specific effect of miR-125b in reducing cell proliferation in HCC cells (Figure 6a).